Loading...
Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa
Tuberculosis is a global threat to which infants are especially vulnerable. Effective vaccines are required to protect infants from this devastating disease. VPM1002, a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) vaccine previously shown to be safe and immunogenic in adults,...
Na minha lista:
| Udgivet i: | Clin Vaccine Immunol |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Microbiology
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5299117/ https://ncbi.nlm.nih.gov/pubmed/27974398 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00439-16 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|